MDMehmet Doğan

Mehmet Doğan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehmet Doğan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • THE RELATIONSHIP BETWEEN HOSPITALISATION DURATION OF PNEUMONIA PATIENTS AND SODIUM LEVEL AND CRP/ALBUMIN RATIO

    by İlKnur Kaya, Ömer Faruk Tekin, Feride Marım, Şebnem Emine Parspur, Mehmet Doğan, Beyza Tas Kaya, Ümran Toru Erbay

    OBJECTIVE: Community-acquired pneumonia (CAP) is a major cause of hospitalizations, increased healthcare costs, lost workdays, and mortality worldwide. Hyponatremia, a common electrolyte disorder in patients with CAP, has been independently associated with increased mortality. mortality. The CRP/albumin ratio is a sensitive marker in many diseases, including malignancies, cardiovascular diseases, infections, and autoimmune diseases. This study aimed to investigate the role of serum sodium levels and the CRP/albumin ratio in predicting the length of hospital stay in patients hospitalized for CAP.MATERIAL AND METHODS: The files of medical records admitted to Kütahya Health Sciences University Faculty of Medicine, Department of Chest Diseases between 01.10.2021-30.09.2022 with a diagnosis of CAP were retrospectively reviewed electronically, and socio-demographic characteristics and laboratory data were recorded.RESULTS: A total of 149 patients, 97 males (65.1%) and 52 females (34.9%), were included in the study. The mean age of the patients was 67.6 ± 15.1 years. When pulmonary involvement was analyzed on thoracic computed tomography (CT), 35.6% (n=53) had 1 single-lobe involvement, 22.2% (n=33) had 2 lobes, 10.1% (n=15) had 3 lobes, 5.4% (n=8) had 4 lobes, and 13.4% (n=20) had 5 lobes. 16.8% (n=25) of the patients had a history of hospitalization due to pneumonia in the previous year, and 5.4% (n=8) had a history of immunosuppressive treatment. When the correlation relationship between the variables was examined, a weak positive correlation (r=0.197, p=0.028) was found between length of hospital stay and the CRP/albumin ratio, but no correlation was identified between the number of hospitalization days and sodium.CONCLUSIONS: Community-acquired pneumonia is an important disease because it causes both loss of labor force and mortality. In our study, which was based on the duration of hospitalization, it was shown that hyponatremia was not associated with, but there was a positive correlation between the CRP/albumin ratio and the duration of hospitalization. This study suggests that the CRP/albumin ratio may be helpful in predicting length of hospital stay.

  • Open Access

    Can biomarkers predict the risk of cardiovascular disease in patients with obstructive sleep apnea syndrome?

    by Hasan Ölmez, Mustafa Tosun, Edhem Ünver, Reşit Çoşkun, Gönül Seven Yalçın, Mehmet Doğan, Yusuf Kemal Arslan

    Background/Aim: Obstructive sleep apnea syndrome (OSAS) is a clinical syndrome characterized by recurrent partial or total obstruction of the upper airway. Cardiovascular disease (CVD) is more common in OSAS patients. Biomarkers can predict the progression of OSAS disease and the occurrence of CVD. Here we investigate the effects of age, gender, body mass index (BMI), comorbidities, neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory index (SII), atherogenic index of plasma (AIP), C-reactive protein-to-albumin ratio (CAR) and monocyte to HDL cholesterol (MHR) on the severity of OSAS and the occurrence of CVD in OSAS patients. Method: This cross-sectional study included 172 OSAS patients presenting to Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital, Sleep Service between 01.01.2021 and 31.08.2022. Polysomnography (PSG) was applied to patients participating in the study, and routine complete blood and biochemistry tests were performed. Comorbidities and demographic data of the participants were recorded. Results: The frequency of CVD, chronic pulmonary disease (CPD) and hyperlipidemia increased as the severity of OSAS increased (P=0.005, PP=0.016, respectively). As the severity of OSAS disease increased, only the MHR indices increased (P=0.009). When OSAS groups with and without CVD were examined, OSAS patients with CVD were older and had higher BMI (PP=0.001, respectively). In addition, tended to be females with hyperlipidemia, diabetes mellitus (DM) and high Charlson Comorbidity Index (CCI) scores (all PP=0.002, P=0.002, P=0.003, PPConclusion: CVD is common in OSAS patients. As the severity of OSAS increases, the risk of developing CVD increases. Elderly female OSAS patients with hyperlipidemic, DM, high BMI, and Charlson Comorbidity Index (CCI) constitute a relatively risky group for CVD. OSAS patients with high AHI, NREM-AHI, RDI, ODI, and low SE values should be monitored more closely for CVD. function ready(callback){ // in case the document is already rendered if (document.readyState!='loading') callback(); // modern browsers else if (document.addEventListener) document.addEventListener('DOMContentLoaded', callback); // IE <= 8 else document.attachEvent('onreadystatechange', function(){ if (document.readyState=='complete') callback(); }); } ready(function(){ var abstract = document.getElementById("abstract"); //declare your possible strings in vars let st = innerHTML; st = st.replace(//g,""); st = st.replace(/<\/p>/g,""); st = st.replace(//g,""); st = st.replace(/<\/strong>/g,""); st = st.replace(/ /g,""); let title = "Background/Aim:"; if(st.includes(title)){ st = st.replace(title, ""+title+" "); } else{ title = "Aim:"; st = st.replace(title, ""+title+""); } let titles = ["Methods:", "Conclusion:", "Results:"]; titles.forEach((title, ndx) => { //console.log(title); st = st.replace(title, " "+title+""); }); //console.log(st); innerHTML = ''+st+''; }); Downloads Download data is not yet available. References Duran J, Esnaola S, Rubio R, Iztueta Á. Obstructive Sleep Apnea–Hypopnea and Related Clinical Features in a Population-based Sample of Subjects Aged 30 to 70 Yr. Am J Respir Crit Care Med. 2001 Mar 17;163(3):685–9. doi: 10.1164/ajrccm.163.3.2005065. DOI: https://doi.org/10.1164/ajrccm.163.3.2005065 Atan D, Kundi FCS, Özcan KM, Dere H. A New Predictor for Obstructive Sleep Apnea Syndrome: Monocyte to HDL Ratio. Indian J Otolaryngol Head Neck Surg. 2017 Jun 11;69(2):142–6. doi: 10.1007/s12070-016-0980-6 DOI: https://doi.org/10.1007/s12070-016-0980-6 Shamsuzzaman A, Gersh B, Somers V. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003 Oct 8;290(14):1906-14. doi: 10.1001/jama.290.14.1906 DOI: https://doi.org/10.1001/jama.290.14.1906 Takama N, Kurabayashi. Influence of untreated sleep-disordered breathing on the long-term prognosis of patients with cardiovascular disease. Am J Cardiol. 2009 Mar 1;103(5):730-4. doi: 10.1016/j.amjcard.2008.10.035 DOI: https://doi.org/10.1016/j.amjcard.2008.10.035 Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes. Circulation Circulation. 2002 Dec 3;106(23):2894-900. doi: 10.1161/01.cir.0000042674.89762.20. DOI: https://doi.org/10.1161/01.CIR.0000042674.89762.20 Imhof B, Aurrand-Lions M. Angiogenesis and inflammation face off. Nat Med. 2006 Feb;12(2):171-2. doi: 10.1038/nm0206-171. DOI: https://doi.org/10.1038/nm0206-171 Lattanzi S, Brigo F, Silvestrini M. Blood pressure profile and nocturnal oxygen desaturation. J Clin Hypertens (Greenwich). 2018 Apr;20(4):656-8. doi: 10.1111/jch.13259. DOI: https://doi.org/10.1111/jch.13259 Lattanzi S, Brigo F, Silvestrini M. Obstructive sleep apnea syndrome and the nocturnal blood pressure profile. J Clin Hypertens (Greenwich). 2018 Jun;20(6):1036-8. doi: 10.1111/jch.13316. DOI: https://doi.org/10.1111/jch.13316 Lattanzi S, Vernieri F, Silvestrini M. Blood pressure variability and neurocognitive functioning. Clin Hypertens (Greenwich). 2018 Apr;20(4):645-7. doi: 10.1111/jch.13232. DOI: https://doi.org/10.1111/jch.13232 Wang J, Shi X, Ma C, Zheng H, Xiao J Bian H, et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2017 Jan;35(1):10-7. doi: 10.1097/HJH.0000000000001159. DOI: https://doi.org/10.1097/HJH.0000000000001159 Tedla YG, Yano Y, Carnethon M, Greenland P. Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness. Hypertension. 2017 Jan;69(1):118-27. doi: 10.1161/HYPERTENSIONAHA.116.08427.14. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.116.08427 Lattanzi S, Carbonari L, Pagliariccio G, Bartolini M. Cagnetti C, Viticchi G, et al. Neurocognitive functioning and cerebrovascular reactivity after carotid endarterectomy. Neurology. 2018 Jan 23;90(4):e307-15. doi:10.1212/WNL.0000000000004862. DOI: https://doi.org/10.1212/WNL.0000000000004862 Ribeiro A, Lotufo P, Fujita C Goulart A, Chor D G Mill J, et al Association between short-term systolic blood pressure variability and carotid intima-media thickness in ELSA-Brasil baseline. Am J Hypertens. 2017 Oct 1;30(10):954-60. doi: 10.1093/ajh/hpx076. DOI: https://doi.org/10.1093/ajh/hpx076 Dursunoğlu N, Dursunoğlu D. Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis. Tuberkuloz ve Toraks. 2005 Jan 1;53(3):299-30 Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010 Dec;7(12):677-85. doi: 10.1038/nrcardio.2010.145. DOI: https://doi.org/10.1038/nrcardio.2010.145 Ryan S, Taylor C, Nicholas MC W. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax. 2009 Jul;64(7):631-6. doi: 10.1136/thx.2008.105577. DOI: https://doi.org/10.1136/thx.2008.105577 Nadeem R, Molnar J, Madbouly E, Nida M, Aggarwal S, Sajid H, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med. 2013 Oct 15;9(10):1003-12. doi: 10.5664/jcsm.3070. DOI: https://doi.org/10.5664/jcsm.3070 Inonu Koseoglu H, Pazarli AC, Kanbay A, Demir O. Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study. Clin Appl Thromb Hemost. 2018 Jan;24(1):139-44. doi: 10.1177/1076029616677803. DOI: https://doi.org/10.1177/1076029616677803 Turak O, Özcan F, İşleyen A, Başar F, Gül M, Yilmaz S, et al. Usefulness of neutrophil-to-lymphocyte ratio to predict in-hospital outcomes in infective endocarditis. Can J Cardiol. 2013 Dec;29(12):1672-8. doi: 10.1016/j.cjca.2013.05.005. DOI: https://doi.org/10.1016/j.cjca.2013.05.005 Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil-to-Lymphocyte Ratio Predicts the Outcome of Acute Intracerebral Hemorrhage. Stroke. 2016 Jun;47(6):1654-7. doi: 10.1161/STROKEAHA.116.013627. DOI: https://doi.org/10.1161/STROKEAHA.116.013627 Lattanzi S, Cagnetti C, Rinaldi C, Angelocola S. Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio improves outcome prediction of acute intracerebral hemorrhage. J Neurol Sci. 2018 Apr 15;387:98-102. doi: 10.1016/j.jns.2018.01.038. DOI: https://doi.org/10.1016/j.jns.2018.01.038 Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. Neutrophil-to-lymphocyte ratio and neurological deterioration following acute cerebral hemorrhage. Oncotarget. 2017 Feb 16;8(34):57489-94. doi: 10.18632/oncotarget.15423. DOI: https://doi.org/10.18632/oncotarget.15423 Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M. Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke. J Neurol Sci. 2018 Apr 15;387:115-8. doi: 10.1016/j.jns.2018.02.002. DOI: https://doi.org/10.1016/j.jns.2018.02.002 Dotsenko O, Chaturverdi N, Thom S, Wright AR, Mayet J, Shore A, et al. Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. J Thromb Haemost. 2007 Oct;5(10):2036-42. doi: 10.1111/j.1538-7836.2007.02711.x. DOI: https://doi.org/10.1111/j.1538-7836.2007.02711.x Duman H, Çinier G, Bakırcı EM, Duman H, Şimşek Z, Hamur H, et al. Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome. Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618824418. doi: 10.1177/1076029618824418. DOI: https://doi.org/10.1177/1076029618824418 Topuz MF, Ture N, Akdag G, Arik O, Gulhan PY. The importance of systemic immune-inflammation index in obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol. 2022 Oct;279(10):5033-8. doi: 10.1007/s00405-021-07227-0. DOI: https://doi.org/10.1007/s00405-021-07227-0 Dobiášová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001 Oct;34(7):583-8. doi: 10.1016/s0009-9120(01)00263-6. DOI: https://doi.org/10.1016/S0009-9120(01)00263-6 Karataş M, Çanga Y, Özcan K, İpek G, Güngör B, Onuk T, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016 Feb;34(2):240-4. doi: 10.1016/j.ajem.2015.10.049. DOI: https://doi.org/10.1016/j.ajem.2015.10.049 Deng X, Gu W, Li Y, Liu M, Li Y, Gao X. Age-group-specific associations between the severity of obstructive sleep apnea and relevant risk factors in male and female patients. PLoS One. 2014 Sep 11;9(9):e107380. doi: 10.1371/journal.pone.0107380. DOI: https://doi.org/10.1371/journal.pone.0107380 Sweed RA, Hassan S, ElWahab NHA, Aref SR, Mahmoud MI. Comorbidities associated with obstructive sleep apnea: a retrospective Egyptian study on 244 patients. Sleep Breath. 2019 Dec;23(4):1079-85. doi: 10.1007/s11325-019-01783-w. DOI: https://doi.org/10.1007/s11325-019-01783-w Ünal M, Öztürk L, Kanik A. The role of oxygen saturation measurement and body mass index in distinguishing between non-apnoeic snorers and patients with obstructive sleep apnoea syndrome. Clin Otolaryngol Allied Sci. 2002 Oct;27(5):344-6. doi: 10.1046/j.1365-2273.2002.00592.x. DOI: https://doi.org/10.1046/j.1365-2273.2002.00592.x Gündüz C, Basoglu OK, Hedner J, Zou D, Bonsignore MR, Hein H, et al. Obstructive sleep apnoea independently predicts lipid levels: Data from the European Sleep Apnea Database. Respirology. 2018 Dec;23(12):1180-9. doi: 10.1111/resp.13372. DOI: https://doi.org/10.1111/resp.13372 Wu W Te, Tsai SS, Shih TS, Lin MH, Chou TC, Ting H, et al. The Association between Obstructive Sleep Apnea and Metabolic Markers and Lipid Profiles. PLoS One. 2015 Jun 26;10(6):e0130279. doi: 10.1371/journal.pone.0130279. DOI: https://doi.org/10.1371/journal.pone.0130279 Gileles-Hillel A, Kheirandish-Gozal L, Gozal D. Biological plausibility linking sleep apnoea and metabolic dysfunction. Nat Rev Endocrinol. 2016 May;12(5):290-8. doi: 10.1038/nrendo.2016.22. DOI: https://doi.org/10.1038/nrendo.2016.22 Jun JC, Drager LF, Najjar SS, Gottlieb SS, Brown CD, Smith PL, et al. Effects of sleep apnea on nocturnal free fatty acids in subjects with heart failure. Sleep. 2011 Sep 1;34(9):1207-13. doi: 10.5665/SLEEP.1240. DOI: https://doi.org/10.5665/SLEEP.1240 Uygur F, Tanriverdi H, Aktop Z, Erboy F, Altinsoy B, Damar M, et al. The neutrophil-to-lymphocyte ratio in patients with obstructive sleep apnoea syndrome and its relationship with cardiovascular disease. Heart Lung. 2016 Mar-Apr;45(2):121-5. doi: 10.1016/j.hrtlng.2016.01.002. DOI: https://doi.org/10.1016/j.hrtlng.2016.01.002 Yayla Ç, Akboğa MK, Gayretli Yayla K, Ertem AG, Efe TH, Şen F, et al. A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio. Biomark Med. 2016 May;10(5):485-93. doi: 10.2217/bmm-2016-0022. DOI: https://doi.org/10.2217/bmm-2016-0022 Zhang Y, Li S, Guo YL, Wu NQ, Zhu CG, Gao Y, et al. Is monocyte to HDL ratio superior to monocyte count in predicting the cardiovascular outcomes: evidence from a large cohort of Chinese patients undergoing coronary angiography. Ann Med. 2016 Aug;48(5):305-12. doi: 10.3109/07853890.2016.1168935. DOI: https://doi.org/10.3109/07853890.2016.1168935 Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med. 2008 Feb 15;177(4):369-75. doi: 10.1164/rccm.200608-1190PP. DOI: https://doi.org/10.1164/rccm.200608-1190PP Campos-Rodriguez F, Martinez-Garcia MA, Reyes-Nuñez N, Caballero-Martinez I, Catalan-Serra P, Almeida-Gonzalez CV. Role of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in women. Am J Respir Crit Care Med. 2014 Jun 15;189(12):1544-50. doi: 10.1164/rccm.201311-2012OC. DOI: https://doi.org/10.1164/rccm.201311-2012OC Wang X, Ouyang Y, Wang Z, Zhao G, Liu L, Bi Y. Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies. Int J Cardiol. 2013 Nov 5;169(3):207-14. doi: 10.1016/j.ijcard.2013.08.088. DOI: https://doi.org/10.1016/j.ijcard.2013.08.088 Loke YK, Brown JWL, Kwok CS, Niruban A, Myint PK. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):720-8. doi: 10.1161/CIRCOUTCOMES.111.964783. DOI: https://doi.org/10.1161/CIRCOUTCOMES.111.964783 Downloads PDF 84 158 Published 2023-02-21 Issue Vol. 7 No. 2 (2023): 160-164 Section Research Article How to Cite 1. Ölmez H, Tosun M, Ünver E, Çoşkun R, Yalçın GS, Doğan M, Arslan YK. Can biomarkers predict the risk of cardiovascular disease in patients with obstructive sleep apnea syndrome? Biomarkers in obstructive sleep apnea syndrome. J Surg Med [Internet]. 2023 Feb. 21 [cited 2023 Dec. 5];7(2):160-4. Available from: https://jsurgmed.com/article/view/7716 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX License Copyright (c) 2023 Hasan Ölmez, Mustafa Tosun, Edhem Ünver, Reşit Çoşkun, Gönül Seven Yalçın, Mehmet Doğan , Yusuf Kemal Arslan This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. Citations #7716